Early lung cancer detection and treatment strategies

Surgical Oncology

Volumn 11, Issue 4, 2002, Pages 191-199

  Port, Jeffrey L ^a   Kent, Michael ^a   Altorki, Nasser K ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

CT Screening; Lung cancer

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; FIBEROPTIC BRONCHOSCOPY; HUMAN; LOBECTOMY; LUNG CARCINOMA; LYMPH NODE; MEDIASTINOSCOPY; PHOTODYNAMICS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SPUTUM CYTODIAGNOSIS; STANDARD; THORACOSCOPY; THORAX RADIOGRAPHY; TREATMENT FAILURE; UNITED STATES;

FEMALE; HUMANS; LUNG NEOPLASMS; MALE; SURVIVAL RATE; TIME FACTORS;

EID: 0036889816     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(02)00049-X     Document Type: Review

References (77)

1. Boring C.C., Squires T.S., Tong T. Cancer statistics 1993. A Cancer Journal for Clinicians. 43:1993;7-26.
2. Wingo P.A., Ries L.A., Giovino G.A., Miller D.S., Rosenberg H.M., Shopland D.R., Thun M.J., Edwards B.K. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. Journal of National Cancer Institute. 91:1999;675-690.
3. Mountain C.F. Revisions in the international system for staging lung cancer. Chest. 111:1997;1710-1717.
4. Flehinger B.J., Melamed M.R., Zaman M.B.et al. Early lung cancer detection. results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study American Review of Respiratory Disease. 130:1984;155.
5. Melamad M.R. Lung cancer screening results in the National Cancer Institute New York study. Cancer. 89:2000;2356-2362.
6. Zhou J., Mulshine J.L., Ro J.Y.et al. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clinical Cancer Research. 4:1998;1631.
7. Mao L., Hruban R.H., Boyle J.O.et al. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Research. 54:1994;1634.
8. Mills NE, Fishman CL, Rom WN, et al. Ras oncogene detection in bronchoalveolar lavage fluid from patients with lung cancer. Lung Cancer 1994;(Suppl. 1):11.
9. Yakubovskaya M.S., Spiegelman V., Luo F.C.et al. High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer. International Journal of Cancer. 63:1995;810.
10. Gasparini S. Bronchoscopic biopsy techniques in the diagnosis and staging of lung cancer. Monaldi Archives of Chest Disease. 52:1997;392-398.
11. Shure D. Fiberoptic bronchoscopy-diagnostic applications. Clinics in Chest Medicine. 8:1987;1-3.
12. Woolner LB. Pathology of cancer detected cytologically. In: Atlas of Early Lung Cancer, National Cancer Institute, National Institute of Health, US Department of Health and Human Services. Tokyo: Igaku-Shoin, 1993. p. 107-213.
13. Lam S. Photodynamic therapy of lung cancer. Seminars in Oncology 1994;21(6)(Suppl.): 15-9.
14. Lam S., Kennedy T.C., Unger M.et al. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest. 113:1998;696-702.
15. Lam S., MacAulay C., leRiche J.C.et al. Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer. 89:2000;2468-2473.
16. Hirsch F.R., Prindiville S.A., Miller Y.E.et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions. a randomized study Journal of National Cancer Institute. 93:2001;1385-1391.
17. Kennedy T.C., Lam S., Hirsch F.R. Review of recent advances in fluorescence bronchoscopy in early localization of central airway lung cancer. The Oncologist. 6:2001;257-262.
18. Melamed M.R., Flehinger R.B., Heelan R.T. Screening for early lung cancer. results of the Memorial Sloan-Kettering study in New York Chest. 86:1984;44-53.
19. Tockman M.S. Survival and mortality from lung cancer in a screened population. the Johns Hopkins Study Chest. 89:1986;325S-326S.
20. Fontana R.S., Sanderson D.R., Woolner L.B.et al. Lung cancer screening. the Mayo Program Journal of Occupational Medicine. 28:1986;746-750.
21. Fontana RS. The Mayo Lung Project: International Conference on Prevention and Early Diagnosis of Lung Cancer. Varese, Italy 1998. p. 15-20.
22. Strauss G.M. Measuring effectiveness of lung cancer screening. from consensus to controversy and back Chest. 112:1997;216S-228S.
23. Flehinger B.J., Kimmel M., Melamed M.R. Survival from early lung cancer. implications for screening Chest. 101:1992;1013-1018.
24. Sobue T., Suzuki R., Matsuda M., Kuroishi T., Ikeda S., Naruke T. Survival for clinical stage I lung cancer not surgically treated. Cancer. 69:1992;685-692.
25. Henscke C., McCauley D., Yankelevitz D., Naidich D., McGuinness G., Miettinen O.et al. Early Lung Cancer Action Project. overall design and findings from baseline screening Lancet. 354:1999;99-105.
26. Yankelevitz D.F., Reeves A.P., Kostis W.J., Zhao B., Henschke C.I. Small pulmonary nodules. volumetrically determined growth rates based on CT evaluation Radiology. 217(1):2000;251-256.
27. Henschke C.I., Naidich D.P., Yankelevitz D.F., McGuinness G., McCauley D.I., Smith J.P.et al. Early lung cancer action project. initial findings on repeat screenings Cancer. 92(1):2001;153.
28. Kubota K., Matsuzawa T., Ito M. Lung cancer imaging by positron emission tomography using C-11 L-methionine. Journal of Nuclear Medicine. 26:1985;37.
29. Nolop K., Rhodes C., Brudin L. Glucose utilization in vivo by human pulmonary neoplasms. Cancer. 60:1987;2682.
30. Prauer H., Weber W., Romer W.et al. Controlled prospective study of positron emission tomography using the glucose analogue [18f] fluorodeoxyglucose in the evaluation of pulmonary nodules. British Journal of Surgery. 85(11):1998;1506.
31. Vansteenkiste J., Stroobants S., DeLyn P.et al. Lymph node staging in non-small cell lung cancer with FDG-PET scan. a prospective study on 690 lymph node stations from 68 patients Journal of Clinical Oncology. 16:1998;2142.
32. Dwamena B., Sonad S., Angobaldo J.et al. Mediastinal staging of non-small cell lung cancer (NSCLC) in the 1990's. a meta-analytic comparison of positron emission tomography and X-ray computed tomography Radiology. 213:1999;530.
33. Bury T., Barreto A., Daenen F.et al. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. European Journal of Nuclear Medicine. 25:1998;1244.
34. Weder W., Schmid R., Bruchhaus H.et al. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Annals of Thoracic Surgery. 66:1998;886.
35. Erasmus J. Jr., Patsy E., McAdams H.et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. American Journal of Roentgenology. 168:1997;1357.
36. Gupta N.C., Graeber G.M., Rogers J.S.et al. Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer. Annals of Surgery. 229:1999;286-291.
37. Graham A.N., Chan K.J., Pastorino U.et al. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 117:1999;246-251.
38. Ishida T., Yano T., Maeda K.et al. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Annals of Thoracic Surgery. 50:1990;708-713.
39. Naruke T., Suemasu K., Ischikawa S. Surgical treatment for lung cancer with metastasis to mediastinal lymph nodes. Journal of Thoracic and Cardiovascular Surgergy. 71:1976;279-285.
40. Naruke T. Significance of lymph node metastases in lung cancer. Seminars in Thoracic and Cardiovascular Surgery. 5:1993;210-218.
41. Oda M., Watanabe Y., Shimizu J.et al. Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer. the role of systematic nodal dissection Lung Cancer. 22:1998;23-30.
42. Robert J.R., Blum M.G., Arildsen R. Prospective comparison of radiologic, thoracoscopic and pathologic staging in patients with early stage non-small cell lung cancer. Annals of Thoracic Surgery. 68:1999;1154-1158.
43. Graham A.N., Chan K.J., Pastorino U.et al. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 117:1999;246-251.
44. Ishida T., Yano T., Maeda K.et al. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Annals of Thoracic Surgery. 50:1990;708-713.
45. Naruke T. Significance of lymph node metastases in lung cancer. Seminars in Thoracic and Cardiovascular Surgery. 5:1993;210-218.
46. Oda M., Watanabe Y., Shimizu J.et al. Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer. the role of systematic nodal dissection Lung Cancer. 22:1998;23-30.
47. Izbicki J.R., Thetter O., Habekost M.et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer. a randomized controlled trial British Journal of Surgery. 81:1994;229-235.
48. Sugi K., Nawata K., Fujita N.et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small cell lung cancer less than. 2 cm in diameter World Journal of Surgery. 22:1998;290-295.
49. Churchill E., Belsey H. Segmental pneumonectomy in bronchiectasis. Annals of Surgery. 109:1939;481.
50. Miller J., Hatcher C. Limited resection of bronchogenic carcinoma in the patients with marked impairment of pulmonary function. Annals of Thoracic Surgery. 44:1987;340-343.
51. Ishida T., Yano T., Maeda K. Strategy for lymphadenectomy in lung cancer. 3 cm or less in diameter Journal of Thoracic and Cardiovascular Surgery. 50:1991;708.
52. Warren W., Faber L. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Journal of Thoracic and Cardiovascular Surgery. 107:1994;1087-1093.
53. Ginsberg R., Rubinstein L. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Annals of Thoracic Surgery. 60:1995;615-623.
54. Okada M., Yoshikawa K., Hatta T., Tsubota N. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of. 2 cm or smaller? Annals of Thoracic Surgery. 956-60:71.
55. Kodama K., Doi O., Higashiyama M., Yokouchi H. Intentional limited resection for selected patients with T1N0M0 non-small cell lung cancer. a single institution study Journal of Thoracic and Cardiovascular Surgery. 114:1997;347-353.
56. Lewis R., Caccavale R., Sisler G., Bocage J., Mackenzie J. One hundred video-assisted thoracic surgical simultaneously stapled lobectomies without rib spreading. Annals of Thoracic Surgery. 63:1997;1415-1422.
57. Kirby T.J., Mack M.J., Landreneau R.J., Rice T.W. Lobectomy - video-assisted thoracic surgery versus muscle-sparing thoracotomy. a randomized trial Journal of Thoracic and Cardiovascular Surgery. 109:1995;997-1001.
58. Giudicelli R., Thomas P., Lonjon T.et al. Video-assisted minithoracotomy versus muscle-sparing thoracotomy for performing lobectomy. Annals of Thoracic Surgery. 58:1994;712-718.
59. McKenna R.J. Jr., Wolf R.K., Brenner M., Fischel R.J., Wurnig P. Is lobectomy by video-assisted thoracic surgery an adequate cancer operation? Annals of Thoracic Surgery. 66:1998;1903.
60. Landreneau R.J., Mack M., Hazelrigg S., Naunheim K., Dowling R., Ritter P.et al. Prevalence of chronic pain after pulmonary resection by thoracotomy or video-assisted thoracic surgery. Journal of Thoracic and Cardiovascular Surgery. 107:1994;1079-1086.
61. Nakata M., Saeki H., Yokoyama N., Kurita A., Takiyama W., Takashima S. Pulmonary function after lobectomy. video-assisted thoracic surgery versus thoracotomy Annals of Thoracic Surgery. 70:2000;938-941.
62. Furuse K., Fukuaka M., Kato H.et al. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early stage lung cancer. Journal of Clinical Oncology. 11:1993;1852.
63. McCaughan J., William T. Photodynamic therapy for endobronchial malignant disease. a prospective fourteen year study Journal of Thoracic and Cardiovascular Surgery. 114:1997;940.
64. Edell E.S., Cortese D.A. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest. 102:1992;1319.
65. Cortese D.A., Edell E.S., Kinsey J.H. Photodynamic therapy for early stage squamous cell carcinoma. Mayo Clinic Proceedings. 72:1997;595.
66. Nesbitt J.C., Putnam J.B., Walsh G.L.et al. Survival in early-stage non-small cell lung cancer. Annals of Thoracic Surgery. 60:1995;466-472.
67. Martini N., Burt M., Bains M.S.et al. Survival after resection of stage II non-small cell lung cancer. Annals of Thoracic Surgery. 54:1992;460.
68. Williams D.E., Pairolero P.C., Danis C.S.et al. Survival of patients surgically treated for stage I lung cancer. Journal of Thoracic and Cardiovascular Surgery. 82:1981;70-76.
69. Moores D., McKneally M. Treatment of stage I lung cancer. Surgical Clinics of North America. 67:1987;945.
70. Martini N., Beattie E.J. Results of surgical treatment of stage I lung cancer. Journal of Thoracic and Cardiovascular Surgery. 74:1977;499.
71. Thomas P., Piantadosi S. Postoperative T1N0 non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 94:1987;349.
72. Weisenburger T., Gail M. The effects of postoperative mediastinal radiation in completely resected stage II epidermoid cancer of the lung. New England Journal of Medicine. 315:1986;1377.
73. Thomas P., Rubinstein L. Malignant disease appearing late after operation for T1N0 non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 106:1993;1053.
74. The Ludwig Lung Cancer Study Group. Patterns of failure in patients with resected stage I and II non-small cell carcinoma of the lung. Annals of Surgery 1987;305:67.
75. Thomas P., Rubinstein L. Cancer recurrence after resection. T1N0 non-small cell lung cancer Annals of Thoracic Surgery. 49:1990;242.
76. Martini N., Bains M., Burt M.et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. Journal of Thoracic and Cardiovascular Surgery. 109:1995;120.
77. Swensen. AM J Respir Crit Care Med 2002;15:165-433.